Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,510.00
+10.00 (0.12%)
At close: Jan 30, 2026

KOSDAQ:318160 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
10,8253,0994,0524,49513,9296,252
Short-Term Investments
494.7311,2079,4332,4007,4636,396
Cash & Short-Term Investments
11,31914,30613,4856,89521,39212,649
Cash Growth
-29.21%6.09%95.59%-67.77%69.12%-57.70%
Accounts Receivable
8,5134,0144,2413,0723,5844,623
Other Receivables
0.5534.9696.4932.52154.821,001
Receivables
8,5144,0494,3373,1043,7395,624
Inventory
9,4834,5508,2819,1066,2544,389
Prepaid Expenses
544.29459.29308.51281.8555.414.22
Other Current Assets
1,010628.87506.67548.41630.85730.2
Total Current Assets
30,87023,99226,91819,93632,07123,406
Property, Plant & Equipment
26,78924,56822,76423,15223,90420,983
Long-Term Investments
2,2491,034644.17548.66509.541,932
Goodwill
-----220.31
Other Intangible Assets
1,4061,2551,282818.32817.77724.56
Long-Term Deferred Tax Assets
-457.97557.14825.57248.8327.4
Other Long-Term Assets
2,8201,5971,030701.66517.12602.47
Total Assets
64,13452,90553,19645,98258,06947,896
Accounts Payable
812.58837.061,048861.031,9531,387
Accrued Expenses
995.69600.95564.82709.24414.39498.58
Short-Term Debt
3,9353,6755,8754,9424,735-
Current Portion of Leases
189.57217.9529.73220.38233.33236.73
Current Income Taxes Payable
547.98462.79540.81573.61,449263.54
Other Current Liabilities
2,190490499.72441.35833.07799.12
Total Current Liabilities
8,6706,2848,5597,7489,6173,185
Long-Term Debt
3,103---9,421-
Long-Term Leases
241.16174.5621.8968.78274.54459.18
Other Long-Term Liabilities
36.734.8453.0760.3429.7639.36
Total Liabilities
12,0516,4938,6347,87719,3423,684
Common Stock
5,1174,6304,6304,1004,1004,100
Additional Paid-In Capital
24,96623,83523,83518,07718,07718,070
Retained Earnings
24,51517,99513,61621,08631,29428,163
Treasury Stock
-5,030-2,833-37.25-7,916-7,916-7,916
Comprehensive Income & Other
2,4862,3382,072-3,648-17,1361,227
Total Common Equity
52,05445,96544,11631,70028,42043,644
Minority Interest
28.64----121.62
Shareholders' Equity
52,08346,41244,56338,10538,72644,213
Total Liabilities & Equity
64,13452,90553,19645,98258,06947,896
Total Debt
7,4694,0685,9275,23214,663695.91
Net Cash (Debt)
3,85110,2387,5581,6636,72811,953
Net Cash Growth
-63.05%35.46%354.48%-75.28%-43.71%-59.35%
Net Cash Per Share
461.841147.60894.55237.54852.311484.50
Filing Date Shares Outstanding
8.158.549.26777.16
Total Common Shares Outstanding
8.158.549.26777.16
Working Capital
22,20017,70918,35912,18722,45420,221
Book Value Per Share
6387.905383.594765.584527.974059.426096.97
Tangible Book Value
50,64844,71042,83430,88227,60242,700
Tangible Book Value Per Share
6215.305236.554627.084411.093942.625964.98
Land
-2,3602,3602,3602,3602,360
Buildings
-8,9868,4428,4598,282422.5
Machinery
-11,56510,28710,74210,6225,304
Construction In Progress
-766.68128.0730.27310.9911,915
Source: S&P Global Market Intelligence. Standard template. Financial Sources.